Monday, September 29, 2014

Hydrocodone Combo Products Moved from Schedule III to Schedule II: What It Means For You

Beginning on October 6, 2014, hydrocodone combination products (HCPs) will be moved from Schedule III to Schedule II substances at the recommendation of the Secretary of the Department of Health & Human Services. This change was included in the Federal Register as part of the Drug Enforcement Agency’s recent publication of its final rule on the matter.  Read here for important need-to-know information on what this change means for family physicians and their patients.

No comments: